Table I.
Comparisons of general data of the hypertensive patients.
| Parameters | PCI group | Control group | P-value |
|---|---|---|---|
| Mean age (years) | 62.47±3.82 | 64.04±4.19 | 0.842 |
| Male, n (%) | 193 (68.9) | 84 (70.0) | 0.747 |
| Smoking, n (%) | 104 (37.1) | 40 (33.3) | 0.673 |
| Fasting blood-glucose (mmol/l) | 5.43±0.43 | 5.51±0.35 | 0.913 |
| Diabetes, n (%) | 79 (28.2) | 32 (26.7) | 0.583 |
| Serum creatinine (µmol/l) | 92.1±9.1 | 93.1±11.8 | 0.738 |
| Homocysteine (µmol/l) | 13.8±2.4 | 13.9±1.7 | 0.545 |
| hs-CRP (mg/l) | 0.89±0.17 | 0.91±0.21 | 0.701 |
| Aspirin, n (%) | 280 (100.0) | 120 (100.0) | 0.662 |
| Clopidogrel, n (%) | 242 (86.4) | 105 (87.5) | 0.843 |
| Ticagrelor, n (%) | 38 (13.6) | 15 (12.5) | 0.274 |
| Statins, n (%) | 276 (98.6) | 114 (95.0) | 0.837 |
| ACEI/ARB, n (%) | 185 (66.1) | 81 (67.5) | 0.583 |
| β-blocker, n (%) | 219 (78.2) | 93 (77.5) | 0.669 |
| Calcium antagonist, n (%) | 86 (30.7) | 38 (31.7) | 0.343 |
| Nitrates, n (%) | 251 (89.6) | 109 (90.8) | 0.554 |
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor antagonist.